Rockwell Medical, Inc. Financial Ratios — RMTI Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	-21.83	-33.82	-59.72	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-62.24	-220.66	-182.75	-31.75	-15.52	-23.16	-36.53	-57.71	-70.46	-50.61	-51.73	-39.24	-17.08	-0.86	-9.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	11.52	13.43	12.71	15.77	16.15	12.67	6.46	-2.5	4.63	4.38	-3.91	5.6	10.41	17.23	16.89
EBITDA Margin (%)	-41.88	-106.69	-87.92	-30.57	-25.8	-36.5	-44.34	-48.52	-51.29	-42.01	-44.92	-22.26	-6.25	2.75	-3.61
Operating Margin (%)	-44.29	-108.87	-89.84	-32.4	-27.28	-37.93	-45.24	-49.55	-55.62	-45.69	-48.98	-23.05	-7.98	0.6	-6.77
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	40.71	- -
Pretax Margin (%)	-43.79	-108.38	-93.13	-39.36	-26.05	-36.41	-45.24	-50.68	-55.67	-49.66	-52.76	-25.65	-10.09	-0.47	-7.67
Profit Margin (%)	-43.79	-108.38	-93.13	-39.36	-26.05	-37.16	-45.24	-50.68	-55.67	-49.66	-52.76	-25.65	-10.09	-0.47	-7.67
Net Income to Common Margin (%)	-43.79	-108.38	-93.13	-39.36	-26.05	-37.16	-45.24	-50.68	-55.67	-49.66	-52.76	-25.65	-10.09	-0.47	-7.67
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-21.83	-33.82	-59.72	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	20	- -	- -	- -	- -	- -	4	24	29	16	13	14	12
ST Debt	- -	- -	2	- -	- -	- -	- -	- -	2	1	10	4	2	2	2
LT Debt	- -	- -	18	- -	- -	- -	- -	- -	2	23	19	12	11	11	11
Total Debt/EBITDA	- -	- -	-0.44	- -	- -	- -	- -	- -	-0.13	-0.92	-1.04	-1.01	-2.57	4.85	-4.99
Net Debt/EBITDA	0.28	0.09	-0.18	3.97	2.18	0.88	0.33	0.74	0.35	1.06	-0.28	0.03	0.09	-2.48	0.65
Total Debt/EBIT	- -	- -	-0.43	- -	- -	- -	- -	- -	-0.12	-0.84	-0.95	-0.98	-2.01	22.26	-2.66
Net Debt/EBIT	0.26	0.09	-0.18	3.75	2.07	0.85	0.32	0.72	0.32	0.98	-0.25	0.02	0.07	-11.38	0.35
EBITDA to Interest Expense	-11,121.88	-55,914.5	-25.27	-3.99	- -	- -	- -	- -	-1,257.68	-13.91	-11.79	-8.37	-2.27	2.22	-2.22
EBITDA-CapEx/Interest Expense	-11,428.91	-56,448.45	-25.63	-4.15	- -	- -	- -	- -	-1,311.2	-14.46	-12.01	-8.51	-2.39	1.42	-2.71
EBIT to Interest Expense	-11,759.63	-57,057.92	-25.83	-4.23	- -	- -	- -	- -	-1,363.8	-15.13	-12.85	-8.67	-2.9	0.48	-4.17
Interest Expense	- -	- -	2	4	- -	- -	- -	- -	- -	2	2	2	2	1	1
Common Equity/Total Assets	35.76	-100.68	-11.92	70.31	72	64.77	56.05	-518.25	-691.63	-433.96	-761.89	-833.62	-761.3	-671.66	-705.2
Long-Term Debt/Equity (%)	0.01	- -	3,008.52	- -	- -	- -	- -	- -	8.76	66.64	752.39	86.66	52.87	34.07	28.62
Long-Term Debt/Capital (%)	0.02	- -	112.74	- -	- -	- -	- -	- -	-0.59	-7.26	-5.59	-3.28	-2.93	-2.89	-2.71
Long-Term Debt/Total Assets (%)	0.01	- -	49.27	- -	- -	- -	- -	- -	4.02	29.29	39.27	26.21	21.57	18.75	18.52
Total Debt/Equity (%)	0.05	-0.02	3,396.09	- -	- -	- -	- -	- -	19.87	70.05	1,139.84	116	63.12	41.54	33.73
Total Debt/Capital (%)	0.08	-0.01	127.26	- -	- -	- -	- -	- -	-1.33	-7.64	-8.47	-4.39	-3.5	-3.52	-3.19
Total Debt/Total Assets (%)	0.03	0.01	55.62	- -	- -	- -	- -	- -	9.11	30.79	59.49	35.09	25.76	22.86	21.83
Net Debt to Equity	-31.33	47.3	1,401.02	-95.78	-50.06	-32.44	-25.54	-83.27	-54.29	-81.16	304.69	-2.93	-2.09	-21.24	-4.38
Net Debt/Capital (%)	-99.99	21.56	208.02	-2,122.59	-97.38	-46.84	-34.26	7.7	3.51	7.66	-2.18	0.11	0.11	1.73	0.4
EBITDA	-21	-53	-46	-17	-14	-19	-25	-31	-31	-26	-28	-16	-5	3	-2
EBITDA-CapEx	-21	-54	-47	-17	-15	-20	-27	-32	-33	-27	-28	-16	-6	2	-3
Operating Income (Loss)	-22	-54	-47	-18	-15	-20	-26	-31	-34	-28	-30	-17	-7	1	-5

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.28	0.17	1.34	8.74	8.74	5.71	3.62	2.54	2.1	4.59	1.07	1.21	0.66	1.53	2.61
Current Ratio	1.89	0.49	1.79	9.66	10.46	7.74	5.34	3.55	2.98	5.43	1.68	2	1.73	2.63	3.98
Quick Ratio	1.59	0.34	1.6	9.2	9.36	6.34	4.31	3.1	2.44	4.91	1.35	1.57	1.31	2.12	3.46
CFO/Avg Current Liab	-1.07	-1.51	-2.26	0.31	-1.49	-1.37	-2.19	-1.83	-2.13	-2.36	-1.99	-0.88	-0.55	0.27	-0.06
Common Equity/Total Assets	35.76	-100.68	-11.92	70.31	72	64.77	56.05	-518.25	-691.63	-433.96	-761.89	-833.62	-761.3	-671.66	-705.2
Long-Term Debt/Equity (%)	0.01	- -	3,008.52	- -	- -	- -	- -	- -	8.76	66.64	752.39	86.66	52.87	34.07	28.62
Long-Term Debt/Capital (%)	0.02	- -	112.74	- -	- -	- -	- -	- -	-0.59	-7.26	-5.59	-3.28	-2.93	-2.89	-2.71
Long-Term Debt/Total Assets (%)	0.01	- -	49.27	- -	- -	- -	- -	- -	4.02	29.29	39.27	26.21	21.57	18.75	18.52
Total Debt/Equity (%)	0.05	-0.02	3,396.09	- -	- -	- -	- -	- -	19.87	70.05	1,139.84	116	63.12	41.54	33.73
Total Debt/Capital (%)	0.08	-0.01	127.26	- -	- -	- -	- -	- -	-1.33	-7.64	-8.47	-4.39	-3.5	-3.52	-3.19
Total Debt/Total Assets (%)	0.03	0.01	55.62	- -	- -	- -	- -	- -	9.11	30.79	59.49	35.09	25.76	22.86	21.83
CFO/Total Liabilities	-78.74	-113.93	-141.65	14.53	-52.26	-41.24	-81.62	-80.77	-113.57	-68.02	-72.84	-52.04	-30.48	15.78	-3.27
CFO/CapEx	-19.05	-60.55	-77.45	6.22	-16.35	-35.05	-12.55	-20.54	-20.37	-28.34	-64.24	-60.25	-33.14	4.16	-1.22
Altman's Z-Score	3.72	-15.77	-3.05	7.12	9.96	3.79	1.38	-4.55	-6.67	-4.62	-10.81	-10.88	-11	-7.43	-9.33

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	11.22	11.52	11.63	11.97	11.63	9.32	8.99	9.51	10.96	14.85	12.28	11.96	9.74	10.58	8.43
Days Sales Outstanding	32.54	31.69	31.39	30.48	31.38	39.18	40.6	38.39	33.29	24.57	29.72	30.51	37.46	34.51	43.3
Inventory Turnover	15.92	16.74	16.78	13.58	7.87	4.65	5.42	11.13	15.21	15.73	16.11	13.9	12.82	14.42	12.51
Days Inventory Outstanding	22.92	21.8	21.75	26.87	46.37	78.49	67.34	32.8	23.99	23.2	22.66	26.26	28.47	25.31	29.17
Accounts Payable Turnover	9.51	4.29	3.9	6.69	10.84	10.31	9.74	14.09	15.47	16.66	16.35	18.09	17.5	22.72	22.68
Accounts Payable Turnover Days	38.4	85.14	93.58	54.56	33.66	35.4	37.47	25.91	23.6	21.91	22.33	20.18	20.86	16.06	16.09
Cash Conversion Cycle	17.06	-31.65	-40.43	2.79	44.09	82.28	70.48	45.28	33.68	25.86	30.04	36.59	45.06	43.76	56.39
Inventory to Cash Days	9.62	9.89	9.64	3.61	-14.98	-39.31	-26.74	5.6	9.3	1.37	7.06	4.25	8.99	9.2	14.13
Inventories	3	3	3	4	8	12	8	4	4	4	4	6	6	6	3
Raw Materials	1	1	1	2	6	11	11	- -	- -	- -	- -	3	2	3	2
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	2	1	1	2	2	3	3	- -	- -	- -	- -	2	3	2	1
Other Inventory	- -	- -	- -	- -	- -	-2	-6	4	4	4	4	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	150	164	344	426	509	333	296	119	149	76	38	10	44	63	30
- Cash & Cash Equivalents	6	5	12	66	31	17	8	23	12	49	13	10	9	16	11
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	20	- -	- -	- -	- -	- -	4	24	29	16	13	14	12
Enterprise Value	133	159	340	340	439	275	263	86	127	42	45	5	47	55	17
Total Capital	11	-17	16	69	63	54	33	-272	-302	-313	-341	-372	-384	-384	-391
Total Debt/Capital (%)	0.08	-0.01	127.26	- -	- -	- -	- -	- -	-1.33	-7.64	-8.47	-4.39	-3.5	-3.52	-3.19
Total Debt / EV	- -	- -	0.06	- -	- -	- -	- -	- -	0.03	0.57	0.64	3.38	0.29	0.24	0.71
EV/Sales	2.71	3.2	6.5	6.27	7.92	5.15	4.59	1.35	2.07	0.67	0.73	0.07	0.56	0.54	0.25
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	19.83	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	90.94	- -
EV/Cash Flow to Firm	- -	- -	- -	40.41	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.13	37.55
EV/Free Cash Flow to Firm	- -	- -	- -	37.37	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.55	17.34
Diluted Market Cap	150	164	344	426	509	333	296	119	149	76	38	10	44	63	30
Diluted Enterprise Value	144	159	352	360	478	315	287	97	141	52	54	16	49	61	32
EV per Share	82.3	86.01	113.61	90.3	97	59.5	56.87	17.88	22.87	6.06	5.27	0.49	2	1.78	0.49
TTM Sales	49	50	52	54	55	53	57	63	61	62	62	73	84	101	69
TTM EBITDA	-21	-53	-46	-17	-14	-19	-25	-31	-31	-26	-28	-16	-5	3	-2
TTM Operating Income	-22	-54	-47	-18	-15	-20	-26	-31	-34	-28	-30	-17	-7	1	-5
TTM Cash Flow to Firm	-11	-31	-49	8	-13	-12	-21	-20	-27	-28	-31	-15	-7	5	- -
TTM Free Cash Flow to Firm	-10	-30	-48	9	-13	-12	-19	-19	-26	-27	-31	-15	-7	6	1

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-14.69	-5.43	-6.88	86.12	-40.69	-27.49	-15.22	-6.15	-5.74	-2.67	-1.16	-0.6	-4.83	12.15	-256.28
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	90.94	- -
Enterprise Value	133	159	340	340	439	275	263	86	127	42	45	5	47	55	17
Low Price	74.8	56.98	34.76	89.1	77.99	39.05	55.66	24.09	19.91	9.13	3.74	0.84	1	1.16	0.78
EV/Sales	2.71	3.2	6.5	6.27	7.92	5.15	4.59	1.35	2.07	0.67	0.73	0.07	0.56	0.54	0.25
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	19.83	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-8.05	-3.27	-4.77	-20.52	-39.65	-18.76	-13.14	-7.9	-6.15	-4.47	-2.46	-1.24	-6.71	-142.31	-8.53
Price/Earnings High	-13.98	-4.44	-10.71	-28.73	-65.17	-27.13	-17.61	-11.38	-12.28	-9.43	-5.68	-3.78	-17.25	-333.23	-16.31
Price/Earnings Low	-5.62	-1.96	-2.14	-15.73	-24.45	-9.1	-9.92	-3.6	-3.23	-2.03	-0.98	-0.44	-2.76	-75.06	-5.28
Price/Book Value	13.14	-9.58	-79.42	6.18	8.05	6.18	8.98	-0.44	-0.48	-0.23	-0.1	-0.03	-0.11	-0.16	-0.07
Price/Book Value Average	15.12	-10.31	-53.69	6.35	9.04	6.9	10.34	-0.93	-0.69	-0.41	-0.22	-0.06	-0.14	-0.17	-0.11
Price/Book Value High	26.24	-13.98	-120.58	8.89	14.86	9.97	13.85	-1.34	-1.37	-0.86	-0.5	-0.18	-0.37	-0.4	-0.22
Price/Book Value Low	10.55	-6.16	-24.04	4.87	5.58	3.35	7.81	-0.42	-0.36	-0.19	-0.09	-0.02	-0.06	-0.09	-0.07
Price/Tangible Book Value	9.1	-14.22	-417.16	6.31	8.32	6.39	9.25	4.53	7.66	2.3	23.82	0.76	4.59	2.95	1.14
Price/Tangible Book Value Average	10.47	-15.29	-281.99	6.49	9.34	7.14	10.65	9.62	10.83	4.15	49.89	1.76	5.89	3.18	1.72
Price/Tangible Book Value High	18.17	-20.75	-633.32	9.09	15.35	10.32	14.27	13.87	21.61	8.76	115.06	5.35	15.14	7.45	3.28
Price/Tangible Book Value Low	7.31	-9.15	-126.27	4.97	5.76	3.46	8.04	4.39	5.68	1.89	19.76	0.63	2.43	1.68	1.06
Price/Sales	3.07	3.29	6.57	7.85	9.2	6.24	5.16	1.88	2.42	1.23	0.62	0.14	0.53	0.62	0.43
Price/Sales Average	3.53	3.54	4.44	8.08	10.33	6.97	5.94	4	3.43	2.22	1.3	0.32	0.68	0.67	0.65
Price/Sales High	6.12	4.81	9.97	11.31	16.98	10.08	7.97	5.77	6.84	4.68	3	0.97	1.74	1.58	1.25
Price/Sales Low	2.46	2.12	1.99	6.19	6.37	3.38	4.49	1.83	1.8	1.01	0.51	0.11	0.28	0.35	0.41
Price/Cash Flow	-13.92	-5.34	-6.79	99.97	-38.2	-26.71	-14.01	-5.85	-5.45	-2.58	-1.15	-0.59	-4.68	15.08	-45.5
Price/Cash Flow Average	-16.02	-5.75	-4.59	102.81	-42.9	-29.83	-16.13	-12.42	-7.71	-4.66	-2.4	-1.37	-6.02	16.26	-68.76
Price/Cash Flow High	-27.79	-7.79	-10.31	143.92	-70.51	-43.14	-21.62	-17.9	-15.38	-9.82	-5.54	-4.17	-15.46	38.07	-131.56
Price/Cash Flow Low	-11.18	-3.44	-2.06	78.77	-26.45	-14.48	-12.18	-5.67	-4.05	-2.12	-0.95	-0.49	-2.48	8.57	-42.58
Price/Free Cash Flow Average	-16.9	-5.84	-4.65	88.57	-45.7	-30.71	-17.53	-13.06	-8.11	-4.83	-2.44	-1.4	-6.21	13.1	-387.31
Price/Free Cash Flow High	-29.33	-7.93	-10.45	123.99	-75.11	-44.41	-23.49	-18.82	-16.17	-10.18	-5.63	-4.24	-15.94	30.68	-741.01
Price/Free Cash Flow Low	-11.8	-3.49	-2.08	67.86	-28.17	-14.9	-13.24	-5.96	-4.25	-2.19	-0.97	-0.5	-2.56	6.91	-239.86
EV/Sales Average	3.41	3.45	4.6	6.86	9.77	6.65	5.8	3.64	3.3	1.82	1.55	0.41	0.73	0.65	0.68
EV/Sales High	6	4.71	10.13	10.09	16.42	9.76	7.82	5.41	6.71	4.28	3.25	1.05	1.79	1.56	1.28
EV/Sales Low	2.34	2.03	2.15	4.97	5.81	3.06	4.34	1.47	1.67	0.61	0.77	0.2	0.33	0.33	0.43
EV/EBITDA Average	-8.14	-3.23	-5.23	-22.46	-37.86	-18.22	-13.08	-7.51	-6.43	-4.34	-3.46	-1.82	-11.69	23.74	-18.84
EV/EBITDA High	-14.33	-4.42	-11.53	-33.03	-63.63	-26.74	-17.63	-11.15	-13.08	-10.19	-7.24	-4.74	-28.7	56.61	-35.4
EV/EBITDA Low	-5.6	-1.9	-2.44	-16.28	-22.5	-8.39	-9.79	-3.02	-3.26	-1.46	-1.71	-0.9	-5.32	12.16	-11.93
EV/EBIT Average	-7.7	-3.17	-5.12	-21.18	-35.8	-17.53	-12.82	-7.35	-5.93	-3.99	-3.17	-1.76	-9.16	108.85	-10.04
EV/EBIT High	-13.56	-4.33	-11.28	-31.15	-60.16	-25.73	-17.28	-10.92	-12.07	-9.37	-6.64	-4.58	-22.49	259.58	-18.86
EV/EBIT Low	-5.29	-1.86	-2.39	-15.35	-21.28	-8.07	-9.6	-2.96	-3.01	-1.34	-1.57	-0.87	-4.16	55.76	-6.36
Last Price	93.17	88.55	114.84	113.08	112.64	72.05	64.02	24.86	26.84	11.11	4.51	1.01	1.89	2.04	0.83
High Price	186.01	129.25	174.35	162.8	207.9	116.38	98.78	76.12	75.68	42.35	21.78	7.15	6.24	5.15	2.41
Enterprise Value Average	167	172	241	372	541	354	332	231	202	113	96	30	61	66	47
Enterprise Value High	294	235	531	547	909	520	448	343	411	266	201	77	150	158	88
Enterprise Value Low	115	101	113	270	321	163	249	93	103	38	48	15	28	34	30

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	2	2	4	5	5	5	5	5	6	9	9	12	29	34	39
Diluted Weighted Avg Shares	2	2	3	4	5	5	5	5	6	7	9	10	23	31	36
Basic Weighted Avg Shares	2	2	3	4	5	5	5	5	6	7	9	10	23	31	36
Revenue per Share	30.39	26.88	17.48	14.4	12.24	11.54	12.4	13.2	11.07	9.05	7.26	7.38	3.58	3.27	1.93
EBITDA per Share	-12.73	-28.68	-15.37	-4.4	-3.16	-4.21	-5.5	-6.41	-5.68	-3.8	-3.26	-1.64	-0.22	0.09	-0.07
Operating Income per Share	-13.46	-29.26	-15.7	-4.66	-3.34	-4.38	-5.61	-6.54	-6.16	-4.13	-3.56	-1.7	-0.29	0.02	-0.13
Basic EPS, GAAP	-13.31	-29.14	-16.28	-5.67	-3.19	-4.29	-5.61	-6.69	-6.16	-4.49	-3.83	-1.89	-0.36	-0.02	-0.15
Basic EPS from Cont Ops	-13.31	-29.14	-16.28	-5.67	-3.19	-4.29	-5.61	-6.69	-6.16	-4.49	-3.83	-1.89	-0.36	-0.02	-0.15
Diluted EPS, GAAP	-13.31	-29.14	-16.28	-5.67	-3.19	-4.29	-5.61	-6.69	-6.16	-4.49	-3.83	-1.89	-0.36	-0.02	-0.15
Diluted EPS from Cont Ops	-13.31	-29.14	-16.28	-5.67	-3.19	-4.29	-5.61	-6.69	-6.16	-4.49	-3.83	-1.89	-0.36	-0.02	-0.15
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-6.69	-16.58	-16.91	1.13	-2.95	-2.7	-4.57	-4.25	-4.92	-4.31	-3.93	-1.72	-0.4	0.14	-0.02
Free Cash Flow per Basic Share	-7.04	-16.86	-17.13	0.95	-3.13	-2.77	-4.93	-4.46	-5.16	-4.46	-3.99	-1.74	-0.42	0.1	-0.03
Cash & Equivalents per Share	10.88	2.54	7.98	22.78	15.64	12.55	7.15	6.98	4.7	8.54	2.63	2.18	0.47	0.7	0.69
Book Value per Share	7.09	-9.24	-1.45	18.3	13.99	11.67	7.13	-56.72	-55.35	-49.08	-43.4	-39.4	-17.03	-12.8	-11.2
Tangible Book Value per Share	10.24	-6.23	-0.28	17.92	13.55	11.27	6.92	5.49	3.5	4.84	0.19	1.34	0.41	0.69	0.73

Rockwell Medical, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)